Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Explore clinical trials studying Refractory Diffuse Large B Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.

3 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Refractory Diffuse Large B Cell Lymphoma (DLBCL) trial results

Recruiting

NCT06116110

Conditions: Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations: Stanford University Stanford, California, United States

Yale University New Haven, Connecticut, United States

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Recruiting

NCT04792489

Conditions: Central Nervous System Lymphoma, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +22 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Mayo Clinic Phoenix, Arizona, United States

UC San Diego Health La Jolla, California, United States

View all 32 locations

Completed

NCT02348216

Conditions: Hemic and Lymphatic Diseases, High Grade B-cell Lymphoma (HGBCL), Immune System Diseases, +13 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

City of Hope Duarte, California, United States

University of California San Diego (UCSD) La Jolla, California, United States

Stanford University Palo Alto, California, United States

View all 36 locations